Figure 1: Chest X-ray pre-and postdiscontinuation of anti TNF-α therapy and commencement of oral prednisolone. (a) Chest X-ray with widespread reticulonodular shadowing with prominence of the of right hilum suggestive of lymphadenopathy pre-anti-TNF-α therapy. (b) Chest X-ray showing improvement in the extent of reticulonodular shadowing post-discontinuation of anti-TNF-α therapy and the commencement of oral prednisolone.